Keros Therapeutics Inc. (KROS)

AI Score

Unlock

14.06

0.53 (3.92%)

At close: Apr 17, 2025, 3:59 PM

14.07

0.07%

After-hours: Apr 17, 2025, 07:47 PM EDT

Keros Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net Income	-46.03M	-52.96M	-45.26M	-43.11M	-40.24M	-39.44M	-37.51M	-35.8M	-29.72M	-23.51M	-27.27M	-24.19M	-6.94M	-20.3M	-15.62M	-15.88M	-10.68M	-12.04M	-10.76M	-11.89M	-2.75M	-3.55M	-2.85M	-3.18M
Depreciation & Amortization	332K	314K	306K	277K	247K	210K	191K	167K	127K	126K	308K	113K	104K	103K	91K	80K	75K	72K	68K	63K	59K	55K	49K	45K
Stock-Based Compensation	9.2M	8.82M	8.79M	8.07M	7.32M	8.71M	7.04M	5.69M	4.75M	4.75M	4.79M	4.39M	3.29M	3.08M	2.85M	2.49M	1.52M	1.42M	1.14M	12K	18K	17K	13K	11K
Other Working Capital	-7.44M	16.09M	-5.82M	-10.07M	129K	-3.62M	-343K	-6.13M	2.48M	-1.2M	-5.29M	723K	-17.78M	1.82M	-3.44M	1.85M	557K	2.77M	-3.42M	2.31M	-3.56M	-914K	-2.71M	-852K
Other Non-Cash Items	572K	-788K	7.91M	9.02M	335K	341K	354K	526K	322K	222K	206K	203K	907K	-589K	103K	99K	98K	49K	91K	1.58M	867K	590K	685K	653K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	26K	n/a	20K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-10.09M	14.11M	-3.98M	-10.13M	6.88M	-3.8M	-913K	-4.81M	3.08M	-6.2M	-632K	18.05M	-16.96M	3.26M	-5.08M	2.71M	990K	-365K	-468K	2.12M	-3.69M	-68K	-2.93M	-39K
Operating Cash Flow	-46.01M	-30.5M	-39.8M	-44.56M	-25.46M	-33.98M	-30.83M	-34.23M	-21.44M	-24.6M	-22.59M	-1.43M	-19.57M	-14.44M	-17.64M	-10.51M	-7.99M	-10.86M	-9.93M	-8.12M	-5.5M	-2.96M	-5.03M	-2.51M
Capital Expenditures	-289K	-386K	-310K	-946K	-541K	-550K	-311K	-1.06M	-351K	-176K	-567K	-147K	-159K	-145K	-510K	-210K	-60K	-30K	-28K	-176K	-18K	-82K	-171K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-289K	-386K	-310K	-946K	-541K	-550K	-311K	-1.06M	-351K	-176K	-567K	-147K	-159K	-145K	-510K	-210K	-60K	-30K	-28K	-176K	-18K	-82K	-171K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.44M	878K	2.9M	5.46M	737K	284K	1.74M	370K	15K	96K	502K	118K	245K	35K	57K	42K	-413K	9K	100.12M	-206K	4K	6K	4K	n/a
Financial Cash Flow	75.54M	155.94M	3.53M	156.8M	69.25M	284K	1.74M	107.68M	61.42M	48.58M	10.19M	118K	28.42M	35K	57K	42K	140.12M	9K	100.12M	55.79M	4K	6K	4K	n/a
Net Cash Flow	29.25M	125.06M	-36.58M	111.3M	43.25M	-34.25M	-29.4M	72.38M	39.62M	23.8M	-12.96M	-1.46M	8.69M	-14.55M	-18.09M	-10.67M	132.07M	-10.88M	90.17M	47.5M	-5.51M	-3.03M	-5.2M	-2.51M
Free Cash Flow	-46.3M	-30.89M	-40.11M	-45.51M	-26M	-34.53M	-31.14M	-35.3M	-21.79M	-24.78M	-23.16M	-1.57M	-19.72M	-14.59M	-18.15M	-10.71M	-8.05M	-10.89M	-9.96M	-8.3M	-5.52M	-3.04M	-5.2M	-2.51M